Top Story

Beta-blockers lowered all-cause mortality in patients with HFpEF

November 25, 2014

Patients with HF with preserved ejection fraction who received treatment with beta-blockers had lower rates of all-cause mortality, according to new study results.

However, the same trend was not observed with beta-blocker use and combined all-cause mortality and hospitalization for HF in this patient population.

Dion Stub, MD, PhD Meeting News CoveragePerspective

Supplemental oxygen increased myocardial injury, infarct size in patients with STEMI

November 25, 2014
CHICAGO — Patients with STEMI and normal oxygen levels who received supplemental oxygen before and during hospitalization exhibited signs of increased myocardial…
Robert J. Russo, MD, PhD Meeting News Coverage

MagnaSafe: MRI safe for patients with pacemakers, ICDs

November 25, 2014
CHICAGO — Patients with pacemakers and implantable cardioverter defibrillators that were not MRI-conditional were able to receive MRIs with almost no clinically…
Jeff Volek In the Journals

Metabolic syndrome risk markers influenced by dietary carbohydrates

November 25, 2014
Dietary fat does not drive up plasma saturated fat in patients with obesity or overweight who have metabolic syndrome, according to research published PLOS
thumbnail for video 3907832195001 Meeting News CoverageVideo

Anna Axelsson, MD: Results from INHERIT do not 'close the door' on losartan

November 24, 2014
CHICAGO — While results from the INHERIT trial indicate that losartan had no effect on left ventricular mass or other clinical endpoints compared with placebo in…
More News Headlines »
Controversial Issues and Challenging Cases

Controversial Issues and Challenging Cases in the New Frontier of Obesity Online Activity

This activity is supported by an educational grant from Eisai Inc.

Obesity has become a world-wide issue of utmost importance as its incidence and prevalence are associated with dramatic…
More »
Meeting News Coverage Video
thumbnail for video 3903437995001

VIDEO: Satellite-based ECG system may improve outcomes for patients with STEMI

November 21, 2014
CHICAGO — Srihari S. Naidu, MD, director of the cardiac catheterization lab at Winthrow University Hospital in…
More »
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »